Evidence map›Paper›PMID 36780469›Full record

ArticlePloS one2023

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR.

Caroline Ngetsa, Victor Osoti, Dorcas Okanda, Faith Marura, Krupali Shah, Henry Karanja, Daisy Mugo, John Gitonga, Martin Mutunga, Clement Lewa and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Caroline NgetsaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Victor OsotiKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Dorcas OkandaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Faith MaruraKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Krupali ShahRevital Healthcare (EPZ) Limited, Mombasa, Kenya.ORCID 0000-0003-4787-7259
Henry KaranjaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Daisy MugoKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
John GitongaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Martin MutungaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Clement LewaKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Benedict OrindiKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Philip BejonKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Lynette Isabella Ochola-OyierKEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research Coast, Kilifi, Kenya.ORCID 0000-0003-4393-0470
Kenya Medical Research Institute · KEChurchill Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Coronavirus Disease-2019 tests require a Nasopharyngeal (NP) and/or Oropharyngeal (OP) specimen from the upper airway, from which virus RNA is extracted and detected through quantitative reverse transcription-Polymerase Chain Reaction (qRT-PCR). The viability of the virus is maintained after collection by storing the NP/OP swabs in Viral Transport Media (VTM). We evaluated the performance of four transport media: locally manufactured ("REVITAL") Viral Transport Media (RVTM), Standard Universal Transport Media (SUTM), PBS and 0.9% (w/v) NaCl (normal saline). We used laboratory cultured virus to evaluate: i) viral recovery and maintaining integrity at different time periods and temperatures; ii) stability in yielding detectable RNA consistently for all time points and conditions; and iii) their overall accuracy. Four vials of SARS-CoV-2 cultured virus (2 high and 2 low concentration samples) and 1 negative control sample were prepared for each media type (SUTM, RVTM, PBS and normal saline) and stored at the following temperatures, -80°C, 4°C, 25°C and 37°C for 7 days. Viral RNA extractions and qRT-PCR were performed at 1, 2, 3, 4 and 7 days after inoculation with the cultured virus to assess virus stability and viral recovery. Ct values fell over time at 25°C and 37°C, but normal saline, PBS, RVTM and SUTM all showed comparable performance in maintaining virus integrity and stability allowing for the detection of SARS-CoV-2 RNA. Overall, this study demonstrated that normal saline, PBS and the locally manufactured VTM can be used for COVID-19 sample collection and testing, thus expanding the range of SARS-CoV-2 viral collection media.

Indexed as

COVID-19SARS-CoV-2COVID-19 TestingHumansReverse Transcriptase Polymerase Chain ReactionRNA, ViralSaline SolutionSpecimen HandlingRNA, ViralSaline Solution

Identifiers

PMID36780469
PMCPMC9924993
OpenAlexW4320484223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.